Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors

Intracellular delivery of protein and RNA therapeutics represents a major challenge. Here, we develop highly potent engineered extracellular vesicles (EVs) by incorporating bio-inspired attributes required for effective delivery. These comprise an engineered mini-intein protein with self-cleavage activity for active cargo loading and release, and fusogenic VSV-G protein for endosomal escape. Combining these components allows high efficiency recombination and genome editing in vitro following EV-mediated delivery of Cre recombinase and Cas9/sgRNA RNP cargoes, respectively. In vivo, infusion of a single dose Cre loaded EVs into the lateral ventricle in brain of Cre-LoxP R26-LSL-tdTomato reporter mice results in greater than 40% and 30% recombined cells in hippocampus and cortex respectively. In addition, we demonstrate therapeutic potential of this platform by showing inhibition of LPS-induced systemic inflammation via delivery of a super-repressor of NF-ĸB activity. Our data establish these engineered EVs as a platform for effective delivery of multimodal therapeutic cargoes, including for efficient genome editing.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-04-29
DOI
https://doi.org/10.1038/s41467-025-59377-y
Citations
49
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
39.49
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors

Oscar P. B. Wiklander, Xiuming Liang, André Görgens, Junhua Xie et al.
49 citations
Nature Communications
Extracellular vesicles in disease
39.49
article

Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors

Oscar P. B. Wiklander, Xiuming Liang, André Görgens, Junhua Xie, Rim Jawad Wiklander, Lien Van Hoecke, Elin K. Esbjörner, Daniel W. Hagey, Radka Slovak, Marziyeh Ghaeidamini, Elien Van Wonterghem, Julia Rädler, Houze Zhou, Doste R. Mamand, Guannan Zhou, Joel Z. Nordin, Samantha Roudi, Antje M. Zickler, Carla Martín Pérez, Antonin de Fougerolles, Roosmarijn E. Vandenbroucke, Thomas C. Roberts, Jeremy Bost, Aileen Geobee Uy, H. Yesid Estupiñán, Samir EL Andaloussi, Vincent Hou, Wenyi Zheng, Zheyu Niu, Dhanu Gupta, Pieter Vader, Justin Hean, Olivier G. de Jong, Dave Carter, Yuanyuan Zong, Matthew J. A. Wood, Imre Mäger, Rui He
article en
49 citations

Abstract

Intracellular delivery of protein and RNA therapeutics represents a major challenge. Here, we develop highly potent engineered extracellular vesicles (EVs) by incorporating bio-inspired attributes required for effective delivery. These comprise an engineered mini-intein protein with self-cleavage activity for active cargo loading and release, and fusogenic VSV-G protein for endosomal escape. Combining these components allows high efficiency recombination and genome editing in vitro following EV-mediated delivery of Cre recombinase and Cas9/sgRNA RNP cargoes, respectively. In vivo, infusion of a single dose Cre loaded EVs into the lateral ventricle in brain of Cre-LoxP R26-LSL-tdTomato reporter mice results in greater than 40% and 30% recombined cells in hippocampus and cortex respectively. In addition, we demonstrate therapeutic potential of this platform by showing inhibition of LPS-induced systemic inflammation via delivery of a super-repressor of NF-ĸB activity. Our data establish these engineered EVs as a platform for effective delivery of multimodal therapeutic cargoes, including for efficient genome editing.

Nature CommunicationsVol. 16(1)
Universidad Industrial de Santander (CO), Uppsala University (SE), Karolinska University Hospital (SE), Utrecht University (NL), Karolinska Institutet (SE), University Medical Center Utrecht (NL), Ghent University (BE), University of Oxford (GB), PsiOxus Therapeutics (United Kingdom) (GB), Shandong Provincial Hospital (CN), VIB-UGent Center for Inflammation Research (BE), Obstetrics and Gynecology Hospital of Fudan University (CN), Oxford BioMedica (United Kingdom) (GB), Shandong First Medical University (CN), University of Tartu (EE), University of Duisburg-Essen (DE), Chalmers University of Technology (SE)
Openalex Percentile: Top 0%
Extracellular vesicles in disease
39.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.